The HBV-ITP group had poor therapeutic effect than non-HBV-ITP group despite of adopting any treatment methods involving high dose immunoglobulin,prednisone and low dose of vincristine(VCR)((χ~2=)12.710,7.884;P<0.05;P=0.007).
The HBV-ITP group had poor therapeutic effect than non-HBV-ITP group despite of adopting any treatment methods involving high dose immunoglobulin,prednisone and low dose of vincristine(VCR)((χ~2=)12.710,7.884;P<0.05;P=0.007).
采用大剂量丙种球蛋白、常规治疗量泼尼松、小剂量长春新碱治疗,HBV-ITP组疗效明显差于非HBV-ITP组(χ2=12.710、7.884,P<0.05,P=0.007)。